Literature DB >> 19851329

Studies of the molecular mechanism of caspase-8 activation by solution NMR.

N Keller1, M G Grütter, O Zerbe.   

Abstract

Caspases are the key players of apoptosis and inflammation. They are present in the cells as latent precursors, procaspases, and are activated upon an apoptotic or inflammatory stimulus. The activation mechanism of caspases has been studied extensively by biochemical and biophysical methods. Additional structural information on active caspases with a variety of different inhibitors bound at the active site is available. In this study, we investigated the cleavage mechanism of caspase-8 from its zymogen to active caspase-8 by solution NMR and by biochemical methods. The intermolecular cleavage reaction using the catalytically inactive C285A procaspase-8 mutant is triggered by adding caspase-8 and followed by (15)N,(1)H-NMR spectroscopy. The spectrum that initially resembles the one of procaspase-8 gradually over time changes to that of caspase-8, and disappearing peaks display exponential decaying intensities. Removal of either one of the cleavage recognition motifs in the linker, or phosphorylation at Tyr380, is shown to reduce the rate of the cleavage reaction. The data suggest that dimerization repositions the linker to become suitable for intermolecular processing by the associated protomer. Furthermore, analysis of inhibitor binding to the active caspase-8 reveals an induced-fit mechanism for substrate binding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19851329     DOI: 10.1038/cdd.2009.155

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  14 in total

1.  Src-inducible association of CrkL with procaspase-8 promotes cell migration.

Authors:  Ryon Graf; Simone Barbero; Nadine Keller; Lauren Chen; Sean Uryu; David Schlaepfer; Dwayne Stupack
Journal:  Cell Adh Migr       Date:  2013-06-10       Impact factor: 3.405

2.  In silico identification and crystal structure validation of caspase-3 inhibitors without a P1 aspartic acid moiety.

Authors:  Rajkumar Ganesan; Stjepan Jelakovic; Peer R E Mittl; Amedeo Caflisch; Markus G Grütter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-07-13

Review 3.  Metacaspases versus caspases in development and cell fate regulation.

Authors:  E A Minina; N S Coll; H Tuominen; P V Bozhkov
Journal:  Cell Death Differ       Date:  2017-02-24       Impact factor: 15.828

Review 4.  Proliferative versus apoptotic functions of caspase-8 Hetero or homo: the caspase-8 dimer controls cell fate.

Authors:  Bram J van Raam; Guy S Salvesen
Journal:  Biochim Biophys Acta       Date:  2011-06-16

5.  Intra- and interdimeric caspase-8 self-cleavage controls strength and timing of CD95-induced apoptosis.

Authors:  Stefan M Kallenberger; Joël Beaudouin; Juliane Claus; Carmen Fischer; Peter K Sorger; Stefan Legewie; Roland Eils
Journal:  Sci Signal       Date:  2014-03-11       Impact factor: 8.192

Review 6.  Caspase-8 as a therapeutic target in cancer.

Authors:  Dwayne G Stupack
Journal:  Cancer Lett       Date:  2010-09-03       Impact factor: 8.679

Review 7.  Caspase-8 as a regulator of tumor cell motility.

Authors:  R P Graf; N Keller; S Barbero; D Stupack
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

8.  Caspase-8 cleaves its substrates from the plasma membrane upon CD95-induced apoptosis.

Authors:  J Beaudouin; C Liesche; S Aschenbrenner; M Hörner; R Eils
Journal:  Cell Death Differ       Date:  2013-01-11       Impact factor: 15.828

Review 9.  Role of caspase-8 in thymus function.

Authors:  N Pozzesi; A Fierabracci; A M Liberati; M P Martelli; E Ayroldi; C Riccardi; D V Delfino
Journal:  Cell Death Differ       Date:  2013-11-22       Impact factor: 15.828

Review 10.  DED or alive: assembly and regulation of the death effector domain complexes.

Authors:  J S Riley; A Malik; C Holohan; D B Longley
Journal:  Cell Death Dis       Date:  2015-08-27       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.